Tag:
RotaTeq
Latest Headlines
Latest Headlines
GAVI signs deal for diarrhea vax for world's poorest
The deal cuts the price for the vaccines 67 percent and means vaccines for 70 million children in the world's 40 poorest countries by 2016.
UPDATED: Academics' oral stomach flu vax could save lives
A new oral vaccine from Australia could help to cut deaths from rotavirus infections, in the developing as well as the developed world.
Merck's RotaTeq not linked with bowel problems
In the past, vaccines against rotavirus, an infection causing severe diarrhea, have been linked with serious bowel problems and blockages in infants, but a large-scale study of over three-quarters of
Merck plans copy of Rotateq in India
MSD Wellcome Trust Hilleman Laboratories, set up in India last year with support from Merck, will attempt to make a copy of the company's Rotateq vaccine for the prevention of diarrhea. Researchers
FDA takes brakes off GSK's Rotarix
Rotavirus vaccines are in the clear. The FDA has decreed that both GlaxoSmithKline's ( NYSE: GSK ) Rotarix and Merck's ( NYSE: MRK ) Rotateq are safe despite their contamination with DNA from a pig virus
Drugmakers: Trypsin likely culprit in Rotavirus vax contamination
Rotavirus vaccine makers say they believe a contaminant of the pig enzyme trypsin, used in the vaccine's manufacture, is responsible for the pig virus detected in both GlaxoSmithKline's ( NYSE: GSK )
Pig-virus DNA found in Merck's rotavirus vax
Remember that pig-virus DNA that turned up in GlaxoSmithKline's vaccine against the diarrhea-causing rotavirus? Well, DNA from the same pig germ has surfaced in Merck's rotavirus preventive. And both
FDA tells doctors to temporarily halt Rotarix use
The FDA is recommending that healthcare practitioners temporarily suspend use of GlaxoSmithKline's Rotarix vaccine for rotavirus immunization in the U.S. while the agency learns more about components
Rotavirus vax draws rave review at annual gathering
A new vaccine that targets rotavirus is being credited as a remarkable success. A slate of studies say that RotaTeq has sliced the number of new cases by anywhere from 66 percent to 100 percent. And
CDC hails Merck's Rotateq for efficacy
Merck has yet another validation of its childhood vaccine Rotateq, designed to prevent rotavirus in infants and children: The CDC says the shot has led to a dramatic drop in hospitalization and ER
